Model also shows routine rapid testing at federally qualified health centers could improve outcomes
WEDNESDAY, July 22, 2020 (HealthDay News) — Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections, according to a study published online June 27 in The American Journal of Medicine.
Sabrina A. Assoumou, M.D., from the Boston Medical Center, and colleagues used individual-level data from 57 FQHCs to model nine strategies of HCV testing and treatment. Clinical outcomes and cost-effectiveness were evaluated for each strategy.
The researchers found that compared with current practice (risk-based with laboratory-based testing), routine rapid point-of-care testing initiated and performed by a counselor identified 68 percent more cases after (nonreflex) RNA testing in the first month of the intervention. Additionally, this strategy led to a 17 percent reduction in cirrhosis cases and a 22 percent reduction in liver deaths among those with cirrhosis over a lifetime. These improved outcomes were achieved with a lower total cost or at lower cost per quality-adjusted life years gained compared with all other strategies.
“Routine anti-HCV testing followed by prompt RNA testing for positives is recommended at FQHCs to identify infections,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Steatotic Liver Disease Risk Scores Compared for Predicting Cirrhosis 
Cirrhosis Can Recur After Liver Transplant 
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery 
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis 
U.S. Adults May Not Understand Their Risk for Vascular Disease 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Machine Learning Model IDs Heart Failure With Reduced Ejection Fraction Using Routine Lab Indicators 
Addition of CAC to PREVENT-ASCVD Equations May Improve Predictive Utility in Certain Patients 
